NorthStar Secures Up to $185 Million Growth Financing Led by Hercules Capital to Scale Actinium-225 Production and Radiopharmaceutical Manufacturing for Next-Generation Precision Cancer Therapies
Go back to NorthStar Secures Up to $185 Million Growth Financing Led by Hercules Capital to Scale Actinium-225 Production and Radiopharmaceutical Manufacturing for Next-Generation Precision Cancer Therapies| HERCULES TECHNOLOGY GROWTH CAPITAL, Inc. (NYSE: HTGC) | Delayed: 16.27 -0.01 (0.06%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $16.28 | 52 Week High | $14.00 | |||
| Open | $16.36 | 52 Week Low | $9.92 | |||
| Day High | $16.36 | P/E | 9.24 | |||
| Day Low | $16.20 | EPS | $1.76 | |||
| Volume | 909,371 | |||||



